Advances in lung cancer and current situation in Romania
Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, On...
Advances in lung cancer and current situation in Romania ( Dr Serban Negru - University of Medicine and Pharmacy Victor Babes Timisoara, OncoHelp Cancer Center )
21 Jun 2021
ALCSI: Raising lung cancer screening awareness in the US
Priyanka Senthil - American Lung Cancer Screening Initiative
ALCSI: Raising lung cancer screening awareness in the US ( Priyanka Senthil - American Lung Cancer Screening Initiative )
17 Jun 2021
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC
Dr Christina Baik - University of Washington School of Medicine, Seattle, USA
Patritumab deruxtecan (HER3-DXd) in EGFR inhibitor-resistant, EGFR-mutated NSCLC ( Dr Christina Baik - University of Washington School of Medicine, Seattle, USA )
11 Jun 2021
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy...
Prof Heather Wakelee - Stanford University, Stanford, USA
IMpower010: Atezolizumab versus best supportive care after adjuvant chemotherapy in resected NSCLC ( Prof Heather Wakelee - Stanford University, Stanford, USA )
11 Jun 2021
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC
Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA
CodeBreaK100: Sotorasib in pretreated KRAS p.G12C mNSCLC ( Dr Ferdinandos Skoulidis - MD Anderson Cancer Center, Houston, USA )
9 Jun 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Jun 2021
OncoAlert and ecancer ASCO roundup - Day 2
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 2 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Jun 2021
OncoAlert and ecancer ASCO roundup - Day 1
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer ASCO roundup - Day 1 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
8 Jun 2021
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve...
Dr Joshua Sabari and Dr Anna Minchom
Amivantamab in combination with lazertinib for osimertinib-relapsed, chemo-naïve EGFRm NSCLC ( Dr Joshua Sabari and Dr Anna Minchom )
8 Jun 2021
NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resect...
Dr Jonathan Spicer - McGill University, Montreal, Canada
NIVO plus chemo vs chemo alone as neoadjuvant treatment for patients with resectable NSCLC ( Dr Jonathan Spicer - McGill University, Montreal, Canada )
4 Jun 2021
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021
Dr Gil Morgan - Skåne University Hospital in Lund, Sweden
OncoAlert and ecancer weekly roundup for April 26 - May 3, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )
7 May 2021
UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients...
Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan
UpSwinG: Real-world, non-interventional cohort study on TKI activity in patients with EGFRm  NSCLC with uncommon mutations ( Dr Satoru Miura - Niigata Cancer Center Hospital, Niigata, Japan )
4 May 2021